お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
984999

COVID-19関連の臨床試験、遠隔医療、ワクチンおよびその他の市場(改訂版)

COVID-19 Update, Clinical Testing, Telehealth, Vaccines and Other Markets

出版日: | 発行: Kalorama Information | ページ情報: 英文 | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.58円
COVID-19関連の臨床試験、遠隔医療、ワクチンおよびその他の市場(改訂版)
出版日: 2020年11月02日
発行: Kalorama Information
ページ情報: 英文
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートは、COVID-19関連の臨床試験、遠隔医療、ワクチンおよびその他の市場の最新の情報を調査しており、市場概要、分子診断・抗原および抗体検査・ワクチンなどの市場変化、タイプ・地域別の分析などの情報を提供しています。

目次

第1章 エグゼクティブサマリー

  • 概要
    • COVID-19件合計
    • 主要国別:COVIDの7日間平均症例数(百万人あたり)の推移
    • COVID-19テスト
  • 範囲と方法調査手法

第2章 COVD-19診断

  • 臨床検査の状況
    • 多数の承認
  • FDAによって承認された検査
    • 分子
    • 免疫学的検査
  • COVID-19情勢を変える抗原検出検査
    • COVID-19市場
  • COVID-19テスト開発
    • LDT市場を左右するCOVID-19
    • 緊急医療センターとCOVID-19検査
    • 様々なSARS-CoV-2抗体キットの精度
    • COVID-19「Nudge」検査の臨床研究における有望性
    • 高感度な新たなCRISPRベースのCOVID-19検査、など
  • 製品開発
    • NIH、BARDA:COVID-19の契約による9,835万米ドルの授与
    • 新たなCOVIDNGS検査
    • Cue:COVID-19テストのためのDODグラントの確保
    • Beckman Coulter:COVID-19IgMアッセイ
    • GenMark:マルチプレックステスト、など
  • 新しい立法
    • COVID-19テストに重要なLDTはAACC別と

第3章 遠隔医療

  • COVID-19がテレヘルスに与える影響
    • COVID-19の要点
    • RPM/テレヘルス市場の実績
  • 企業の実績
    • ABBOTT
    • AMERICAN WELL (AMWELL)
    • ASCOM HOLDING AG
    • BRIGHT.MD
    • DOCTOR ON DEMAND
    • EKO DEVICES
    • G MEDICAL INNOVATIONS HOLDING LTD.
    • GENERAL DEVICES
    • GLOOKO
    • MASIMO
    • MEDTRONIC
    • OSI SYSTEMS
    • PHILIPS - KONINKLIJKE PHILIPS N.V. (ROYAL PHILIPS)
    • TELADOC HEALTH
    • THINKLABS
    • TYTOCARE

第4章 COVID-19とライフサイエンス調査

  • 調査室のシャットダウンとステータスの拒否
  • COVID-19の調査と出版物
  • COVID-19治療法開発のための調査抗体
  • ライフサイエンスツール市場の考慮事項

第5章 ワクチン

  • 米国の成人は、COVID-19ワクチンをどのように受け入れるか
  • ユニバーサルコロナウイルスワクチン?
    • Moderna:中東・アフリカからの賛同、および販売承認の提出
目次
Product Code: 20-036

COVID-19 continues to be a dominant issue for healthcare systems worldwide and in the United States. Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic.

Particular sections address the most important market changes:

  • Molecular Diagnostics: COVID-19 has seen the molecular in vitro diagnostics (IVD) industry bring out its best efforts in terms of fast test RT-PCR tests for their systems, point of care solutions, syndromic tests, high throughput systems and surge production on badly needed kits.
  • Antigen and Antibody Tests: Never have immunoassays been of such worldwide attention, as antibody tests are greatly sought. With this, come concerns about accuracy levels on broad populations and greater knowledge about development times. There are now immunoassays in development. We track these efforts and provide commentary on the role of these tests in a threat so far dominated by molecular diagnostics.
  • Vaccines: We look at the vaccines in development and the struggles with vaccine discovery and manufacturing in other pandemics.
  • Life Science Research - what are the trends in experiments and publications, how has COVID-19 affected lab research volume and tools markets.
  • Remote Patient Monitoring: Already a healthcare trend that was catching on but perhaps struggling to convince payors of its critical necessity, remote patient monitoring and telehealth transformed overnight with social distancing policies and relaxed HIPAA rules. Kalorama has contacted a number of companies for October 2020 updates.

As part of this report's offerings, the following information is included:

  • Market for COVID-19 by Type: PCR, Antigen, Antibody
  • Market for COVID-19 by Region: US, Europe, Asia, ROW
  • Current EUA Test Approvals
  • Antigen COVID-19 Tests
  • Overall Clinical Lab Volume Trends (April to September)
  • Market for Telehealth and COVID-19 Impact
  • Telehealth Company Responses to COVID-19
  • COVID-19 Vaccines in Development
  • COVID-19 Vaccine Pre Sales

This report does not seek to provide a data-driven market assessment due to the rapidly-changing situation, but does provide analyst commentary that may assist customers needing to work out models. Some of Kalorama Information's market estimates provide foundational bases on which to judge potential market impact.

Commentary and analysis from Kalorama authors who have studied markets in some cases for decades add understanding to the current, often chaotic, market atmosphere. Further publications and surveys from Kalorama Information will provide additional market impact data.

Companies Discussed Include:

  • Abbott
  • American Well (Amwell)
  • Ascom Holding
  • Astra Zeneca
  • Beckman Coulter
  • Becton Dickinson
  • Bright.Md
  • Cepheid
  • Cue Health
  • Doctor On Demand
  • Eko Devices
  • Eurofins
  • G Medical Innovations Holding Ltd.
  • General Devices
  • Genmark
  • Hologic
  • Johnson and Johnson
  • Medtronic
  • Moderna
  • Philips
  • Qiagen
  • Quidel
  • Roche
  • Teladoc Health

TABLE OF CONTENTS

CHAPTER 1: EXECUTIVE SUMMARY

  • OVERVIEW
    • COVID-19 Cases Total
    • COVID Cases Rolling 7-Day Average Per Million by Major Countries
    • COVID-19 TESTING
  • SCOPE AND METHODOLOGY

CHAPTER 2: COVD-19 DIAGNOSTICS

  • CLINICAL LAB SITUATION
    • Table: Clinical Labs Percent of Labs Experiencing Volume Declines Due to COVID-19 and Shutdowns [Major, Minor, No Decline]
    • Large Number of Approvals
  • TEST APPROVED BY FDA
    • Molecular
    • Immunoassays
      • Table: Tests for COVID-19 Authorized by FDA
  • ANTIGENT TESTS CHANGE COVID-19 LANDSCAPE
    • COVID-19 MARKET
      • Figure : IVD COVID-19 Market, Distribution by Region (North America, Europe, Asia Pacific, RoW), 2020 % KOREAN COVID-19 TESTING FOCUS
  • COVID-19 TESTING DEVELOPMENTS
    • COVID Driving LDT Market
    • CMS Seeks to Spur Speed of Results by Cutting Fees for Slower Labs
    • Urgent care Centers and COVID-19 testing
    • Study finds SARS-CoV-2 antibody kits have varying accuracy
    • COVID-19 "Nudge" Test shows promise in clinical study
    • New CRISPR-based COVID-19 test shows high sensitivity
    • Blood test score helps predict COVID-19 severity
    • Biomarkers to determine COVID-19 odds: GW researchers
  • PRODUCT DEVELOPMENTS
    • NIH, BARDA award $98.35M in COVID-19 Contracts
    • New COVID NGS Test
    • Cue secures DOD Grant for COVID-19 tests
    • Beckman Coulter COVID-19 IgM assay
    • GenMark Multiplex test
    • 20/20 takes orders for 1st POC Fingerstick COVID-19 test
    • Quidel gets EUA for Combo flu, COVID-19 test
    • Biocept reaches COVID-19 testing milestone
    • LabCorp nabs EUA for new COVID-19 molecular test
    • FDA issues EUA for OralDNA's oral rinse COVID-19 test
    • LDTs AND COVID-19
  • NEW LEGISLATION
    • LDTs Critical for COVID-19 Testing, Says AACC

CHAPTER 3: TELEHEALTH

  • COVID-19 IMPACT ON TELEHALTH: KEY TAKEAWAYS
    • COVID-19 Key Takeaways
    • RPM/Telehealth Market Performance
  • COMPANY RESULTS
    • ABBOTT
    • AMERICAN WELL (AMWELL)
    • ASCOM HOLDING AG
    • BRIGHT.MD
    • DOCTOR ON DEMAND
    • EKO DEVICES
    • G MEDICAL INNOVATIONS HOLDING LTD.
    • GENERAL DEVICES
    • GLOOKO
    • MASIMO
    • MEDTRONIC
    • OSI SYSTEMS
    • PHILIPS - KONINKLIJKE PHILIPS N.V. (ROYAL PHILIPS)
    • TELADOC HEALTH
    • THINKLABS
    • TYTOCARE

CHAPTER 4. COVID-19 AND LIFE SCIENCE RESEARCH

  • RESEARCH LAB SHUTDOWN AND DECLINE STATUS
  • COVID-19 RESEARCH AND PUBLICATIONS
  • SHINING A SPOTLIGHT IN A CHALLENGED MARKET: RESEARCH ANTIBODIES FOR COVID-19 THERAPEUTIC DEVELOPMENT
  • LIFE SCIENCE TOOLS MARKET CONSIDERATIONS

CHAPTER 5. VACCINES

  • Figure: COVID-19 Per Capita Doses Ordered by Country
  • Figure: COVID-19 Vaccine Candidates: Government Presales
  • HOW WILLING ARE U.S. ADULTS TO ACCEPT A COVID-19 VACCINE?
  • UNIVERSAL CORONAVIRUS VACCINES?
    • Moderna gets nod from EMA to submit marketing authorization
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.